Skip to main content
. 2006 Mar;44(3):1184–1186. doi: 10.1128/JCM.44.3.1184-1186.2006

TABLE 1.

Case reports of Ochrobactrum anthropi infection in immunocompetent hosts

Reference or source Yr Age (yr)/sex Diagnosis Contributing factor Treatmenta
3 1987 14/M Osteochondritis Foot trauma CLI/RIF
5 1993 74/F Necrotizing fasciitis Unknown IPM
4 1996 66/M Endophthalmitis Cataract surgery CIP
6 1996 29/M Cellulitis Foot trauma RAD
10 1997 45/M Sepsis Venous catheter None
8 1997 40/F Chest wall abscess Foreign body VAN/RIF/CIP/SXT
13 1999 64/M Endophthalmitis Vitrectomy IPM/MIN/CIP
14 1999 2/M Osteomyelitis Unknown CLI/RIF
16 2000 39/F Endocarditis Contaminated pharmaceuticals VAN/GEN/OFX
11 2001 61/M Endophthalmitis Cataract extraction VAN/GEN/CAZ/CLI
20 2002 62/F Osteomyelitis Unknown CRO/CIP
15 2003 30/F Sepsis Contaminated pharmaceuticals OFX/GEN
17 2003 30/F Sepsis Trauma Unknown
19 2004 65/F Endocarditis Prosthetic valve MEM/GEN
18 2005 64/F Endocarditis Prosthetic valve Unknown
PRb 2005 49/M Pelvic abscess Abdominal surgery LVX/metronidazole
a

CAZ, ceftazidime; CIP, ciprofloxacin; CLI, clindamycin; CRO, ceftriaxone; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; OFX, ofloxacin; RAD, cephradine; RIF, rifampin; SXT, trimethoprim-sulfamethoxazole; VAN, vancomycin.

b

PR, present report.